Nanoformulated ssRNA-based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer to Induce a Humoral Immune Response by Activation of Antigen-presenting Cells.

: As agonists of TLR7/8, single-stranded RNAs (ssRNAs) are safe and promising adjuvants that do not cause off-target effects or innate immune overactivation; however, low stability prevents them from mounting sufficient immune responses. This study aimed to evaluate the adjuvant effects of ssRNA derived from the cricket paralysis virus intergenic region internal ribosome entry site, formulated as nanoparticles with a coordinative amphiphile, containing a zinc/dipicolylamine complex moiety as a coordinative phosphate binder. We applied our amphiphile system as a stabilizer for RNA-based adjuvants. The nanoformulated ssRNA-based adjuvant was resistant to enzymatic degradation in vitro and in vivo. The ssRNA-based adjuvant formulated with a coordinative amphiphile bearing an oleyl group (CA-O) was approximately100 nm, promoted effective recognition and improved activation of antigen-presenting cells, leading to better induction of neutralizing antibodies following single immunization. Hence, CA-O may increase the efficacy of ssRNA-based adjuvants, proving useful to meet the urgent need for vaccines during pathogen outbreaks.